Revenue | ₹0.20Cr |
Net Profits | ₹0.50Cr |
Net Profit Margins | -250% |
Venmax Drugs & Pharmaceuticals Ltd’s revenue jumped 300% since last year same period to ₹0.20Cr in the Q3 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 17.65% jump in its revenue since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit fell -1766.67% since last year same period to ₹0.50Cr in the Q3 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -66.67% fall in its net profits since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit margin fell -516.67% since last year same period to -250% in the Q3 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -41.67% fall in its net profit margins since last 3-months.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.20Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.50Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was -250%.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹0.05Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was ₹0.03Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2023 was 60%.